COMMUNIQUÉS West-GlobeNewswire

Supernus Announces Third Quarter 2024 Financial Results
04/11/2024
Net sales of Qelbree ® increased 68% in the third quarter of 2024, compared to the same period in 2023. Net sales of Qelbree of $62.4 million and $166.9 million in the third quarter and first nine months of 2024, [...]
Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 Outlook
04/11/2024
Inspire Reports Year-over-Year Revenue Growth of 33% and Earnings per Share of $0.60 in the Third Quarter MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the [...]
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
04/11/2024
SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024
04/11/2024
-- Real-world data showed mean BMI decrease of 12.8% in adult patients with acquired hypothalamic obesity (N=8) at three months on setmelanotide therapy; mean BMI decrease of 21.3% in patients (n=5) who reached six [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/11/2024
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 31, 2024 it granted stock options to purchase an aggregate of 17,712 shares of [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/11/2024
WESTLAKE VILLAGE, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare
04/11/2024
Inovalon Unveils New Research, Products, and Solutions to Tackle Healthcare’s Most Complex Challenges BOWIE, Md., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software solutions [...]
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
04/11/2024
VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“ Bright Minds ” or the “ Company ”) announces that further to its news release of October 18, [...]
Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support
04/11/2024
WARREN, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]
Sienna Announces Change of timing to Third Quarter 2024 Conference Call
04/11/2024
MARKHAM, Ontario, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a change in the timing of its upcoming 2024 third quarter conference call with the [...]
Grant of Warrants
04/11/2024
4 November 2024 Announcement no. 21 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, November 4, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has [...]
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
03/11/2024
SAN DIEGO, Nov. 03, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting [...]
KFSHRC & Lilly Collaborate in Alzheimer’s Early Detection
03/11/2024
RIYADH, Saudi Arabia, Nov. 03, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia signed an MoU today to improve Alzheimer’s patient care. The Memorandum [...]
Optimal Breathing Holds its Annual Black Friday Sale
02/11/2024
FORT MILL, S.C., Nov. 02, 2024 (GLOBE NEWSWIRE) -- Optimal Breathing will hold its annual Black Friday Sale online at www.optimalbreathing.com , starting November 1, 2024. This sale will offer customers a flat 15% OFF [...]
Merus annonce ses résultats financiers pour le troisième trimestre 2024 et fait le point sur ses activités
02/11/2024
L’inclusion est en cours pour les essais d’enregistrement de phase III, pour l’évaluation du pétosemtamab en association avec le pembrolizumab en traitement de 1re intention, et pour l’évaluation du pétosemtamab en [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/11/2024
SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics [...]
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/11/2024
ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted two newly-hired [...]
HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
01/11/2024
— Hospital Outpatient Prospective Payment System reimbursement rate doubled, expanding access to CCTA and supporting the technology’s superior accuracy and efficiency in cardiac care — New payment rates also confirmed [...]
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
01/11/2024
Poster presentation will highlight new data from clinical trial evaluating evorpacept, a highly differentiated investigational CD47 blocker, in combination with zanidatamab, an investigational dual HER2-targeted [...]

Pages